Epidemiology, Diagnosis, and Treatment of Scabies in a Dermatology Office

References

1. 1.↵
   1. Hengge UR,
   2. Currie BJ,
   3. Jager G,
   4. Lupi O,
   5. Schwartz RA

   . Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 2006;6:769–79.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   Epidemiology and management of common skin diseases in children in developing countries. Geneva, Switzerland: World Health Organization; 2005.
3. 3.↵
   1. Chosidow O

   . Clinical practices. Scabies. N Engl J Med 2006;354:1718–27.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Feldmeier H,
   2. Heukelbach J

   . Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues. Bull World Health Organ 2009;87:152–9.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Dupuy A,
   2. Dehen L,
   3. Bourrat E,
   4. et al

   . Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007;56:53–62.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Argenziano G,
   2. Fabbrocini G,
   3. Delfino M

   . Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabiei. Arch Dermatol 1997;133:751–3.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Brunetti B,
   2. Vitiello A,
   3. Delfino S,
   4. Sammarco E

   . Findings in vivo of Sarcoptes scabiei with incident light microscopy. Eur J Dermatol 1998;8:266–7.

   OpenUrlPubMed
8. 8.↵
   1. Johnston G,
   2. Sladden M

   . Scabies: diagnosis and treatment. BMJ 2005;331:619–22.

   OpenUrlFREE Full Text
9. 9.↵
   1. Hicks MI,
   2. Elston DM

   . Scabies. Dermatol Ther 2009;22:279–92.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Strong M,
    2. Johnstone P

    . Interventions for treating scabies. Cochrane Database Syst Rev 2007;(3):CD000320.
11. 11.↵
    1. Heukelbach J,
    2. Feldmeier H

    . Scabies. Lancet 2006;367:1767–74.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Thomas J,
    2. Peterson GM,
    3. Walton SF,
    4. Carson CF,
    5. Naunton M,
    6. Baby KE

    . Scabies: an ancient global disease with a need for new therapies. BMC Infect Dis 2015;15:250.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Goldust M,
    2. Rezaee E,
    3. Hemayat S

    . Treatment of scabies: comparison of permethrin 5% versus ivermectin. J Dermatol 2012;39:545–7.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Usha V,
    2. Gopalakrishnan Nair TV

    . A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000;42:236–40.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Hay RJ,
    2. Steer AC,
    3. Engelman D,
    4. Walton S

    . Scabies in the developing world–its prevalence, complications, and management. Clin Microbiol Infect 2012;18:313–23.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Burkhart CG,
    2. Burkhart CN,
    3. Burkhart KM

    . An epidemiologic and therapeutic reassessment of scabies. Cutis 2000;65:233–40.

    OpenUrlPubMed
17. 17.↵
    1. Bouvresse S,
    2. Chosidow O

    . Scabies in healthcare settings. Curr Opin Infect Dis 2010;23:111–8.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Ladbury G,
    2. Morroy G,
    3. van Hoeven-Dekkers S,
    4. et al

    . An outbreak of scabies in multiple linked healthcare settings in The Netherlands. Infect Control Hosp Epidemiol 2012;33:1047–50.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Hewitt KA,
    2. Nalabanda A,
    3. Cassell JA

    . Scabies outbreaks in residential care homes: factors associated with late recognition, burden and impact. A mixed methods study in England. Epidemiol Infect 2015;143:1542–51.

    OpenUrlCrossRef
20. 20.↵
    1. de Beer G,
    2. Miller MA,
    3. Tremblay L,
    4. Monette J

    . An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control. Infect Control Hosp Epidemiol 2006;27:517–8.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Pannell RS,
    2. Fleming DM,
    3. Cross KW

    . The incidence of molluscum contagiosum, scabies and lichen planus. Epidemiol Infect 2005;133:985–91.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Jayaraj R,
    2. Hales B,
    3. Viberg L,
    4. et al

    . A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn Microbiol Infect Dis 2011;71:403–7.

    OpenUrlPubMed
23. 23.↵
    Centers for Disease Control and Prevention. Expedited partner therapy in management of sexually transmitted diseases. Atlanta: US Department of Health and Human Services; 2006.
24. 24.↵
    1. Currie BJ,
    2. Harumal P,
    3. McKinnon M,
    4. Walton SF

    . First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004;39:e8–12.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Pasay C,
    2. Arlian L,
    3. Morgan M,
    4. et al

    . High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med Vet Entomol 2008;22:82–8.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Mounsey KE,
    2. Holt DC,
    3. McCarthy J,
    4. Currie BJ,
    5. Walton SF

    . Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol 2008;3:57–66.

    OpenUrlCrossRefPubMed